ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

PHILIP JAMESON MD

8312 KASEMAN CT NE PMG KASEMAN ADULT HEALTHCARE

Albuquerque | New Mexico | 87110

(505) 291-2200

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,271Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 229

$697K Total Retail Price of All Prescriptions

Rank: 22 out of 229

950 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 950 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 950 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,170 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 636 604 1 3
LISINOPRIL 516 463 2 2
AMLODIPINE BESYLATE 489 474 3 5
LEVOTHYROXINE SODIUM 472 456 4 1
OMEPRAZOLE 385 372 5 4
HYDROCHLOROTHIAZIDE 377 351 6 9
HYDROCODONE-ACETAMINOPHEN 311 259 S3 7 7
TAMSULOSIN HCL 208 200 8 24
FUROSEMIDE 205 188 9 8
GABAPENTIN 205 190 9 10
ALENDRONATE SODIUM 184 180 11 14
LOSARTAN POTASSIUM 171 171 12 12
ATENOLOL 169 159 13 19
PANTOPRAZOLE SODIUM 167 147 14 33
CRESTOR 167 146 14 30
ATORVASTATIN CALCIUM 164 141 16 15
FLUTICASONE PROPIONATE 162 152 17 23
METFORMIN HCL 160 126 18 6
WARFARIN SODIUM 129 127 19 17
SERTRALINE HCL 127 113 20 22
LOVASTATIN 126 120 21 11
TRAZODONE HCL 120 100 22 34
DIOVAN 116 107 23 42
SPIRIVA 115 102 24 76
BUPROPION HCL SR 115 73 24 121
METOPROLOL SUCCINATE 110 107 26 16
POTASSIUM CHLORIDE 106 104 27 18
METOPROLOL TARTRATE 106 95 27 13
ZOLPIDEM TARTRATE 101 95 29 20
TRAMADOL HCL 98 89 30 26
ALLOPURINOL 95 93 31 27
OXYCODONE HCL 90 67 S2 32 37
CITALOPRAM HBR 79 64 33 21
CLONIDINE HCL 79 77 33 69
RANITIDINE HCL 75 72 35 32
PRAVASTATIN SODIUM 71 70 36 25
TRIAMTERENE-HCTZ 70 63 37 51
DILTIAZEM ER 69 69 38 123
MIRTAZAPINE 65 65 39 52
FINASTERIDE 62 62 40 55
GEMFIBROZIL 62 61 40 62
DONEPEZIL HCL 61 61 42 29
VENLAFAXINE HCL ER 61 48 42 122
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 59 44 28
PAROXETINE HCL 60 45 44 49
PROAIR HFA 59 42 46 38
GLIMEPIRIDE 58 55 47 63
LANTUS SOLOSTAR 57 39 48 85
FENTANYL 57 41 S2 48 108
PREDNISONE 56 52 50 35
MELOXICAM 55 47 51 45
SPIRONOLACTONE 55 54 51 56
VERAPAMIL ER 55 53 51 194
FLUOXETINE HCL 55 55 51 41
OXYCODONE-ACETAMINOPHEN 52 28 S2 55 43
ESTRADIOL 52 49 R 55 138
FLOVENT HFA 50 47 57 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.